Can a Patient's own immune cells fight back against recurrent brain cancer?
Cure
Not yet recruiting
Researchers are testing CHANK-101, a therapy made from a patient's own natural killer (NK) cells, in adults with glioblastoma that has returned after standard treatment. The study enrolls 60 participants who receive intravenous infusions of these cells every two weeks for up to 1…
Sponsor: Dong-A University Hospital • Aim: Cure
Last updated Sep 22, 2026 04:00 UTC